Merida Biosciences, Inc.
All
Newsflash
Article
-
Eli Lilly to acquire Merida Biosciences for up to $2.88 billion, expanding into autoimmune diseases beyond obesity drugs
Eli Lilly agreed to acquire Merida Biosciences for up to $2.88 billion in cash, a move aimed at diversifying its pipeline into autoimmune diseases. The deal, expected to close in Q4 2026, will help Li
-
Eli Lilly to acquire Merida Biosciences for up to $2.88 billion, expanding into autoimmune diseases beyond obesity drugs
Eli Lilly agreed to acquire Merida Biosciences for up to $2.88 billion in cash, a move aimed at diversifying its pipeline into autoimmune diseases. The deal, expected to close in Q4 2026, will help Li
- No data
Merida Biosciences, Inc.
Svmuu provides news and information related to Merida Biosciences, Inc., as well as real-time data on Merida Biosciences, Inc.. We provide in-depth analysis and interpretation of the latest Merida Biosciences, Inc. developments, helping investors stay informed about Merida Biosciences, Inc. policy updates. Svmuu is your essential tool for keeping up with the latest Merida Biosciences, Inc. trends! Here, we’ll join you in keeping a close eye on Merida Biosciences, Inc. news and use a clear macro perspective to make sense of the uncertain future of crypto.
24H Trending
-
1
Oracle, Meta, and SpaceX credit default swaps (CDS) hit all-time highs, as the market anticipates a surge in AI-related bond issuance in Q4.
-
2
Liu Jun, President of Industrial and Commercial Bank of China (ICBC): Commercial Banks Bear Heavier Financial and Legal Responsibilities Than Central Banks in AI Deployment
-
3
Bain Survey: Chinese Consumers Prioritize Technology in Car Purchases, While Europeans and Americans Still Value Price; Western Automakers Face Dual Pressure
-
4
Anthropic pitches AI safety bill that would require judge's permission to block models
-
5
Anthropic reportedly faces a compute shortage as cloud giants view it as a competitor, plans November IPO.
-
6
NextDC's data center project in Australia faces power supply delays due to resident protests, leading to a more than one-third reduction in its FY2027 earnings guidance and a 45% plunge in its stock price.
-
7
Media reports: Amazon Web Services (AWS) has billions of dollars worth of NVIDIA chips backlogged in its warehouses due to power shortages, leading to negative free cash flow.
-
8
Hansoh Pharmaceutical inks up to $15B drug deal with Roche, China's innovative drug out-licensing hits $130B
-
9
King Charles III of the UK praised Oman's peaceful efforts in reopening the Strait of Hormuz.
-
10
U.S. equity index futures rose, boosted by strong earnings reports from AI-related companies.
Markets Today
Recommended Reading
